wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53147059-E4624EE8-7C21-44C3-B85E-6D58F7582280
Q53147059-E4624EE8-7C21-44C3-B85E-6D58F7582280
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53147059-E4624EE8-7C21-44C3-B85E-6D58F7582280
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment.
P2860
Q53147059-E4624EE8-7C21-44C3-B85E-6D58F7582280
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53147059-E4624EE8-7C21-44C3-B85E-6D58F7582280
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f21cbcddde54e00be8fa7335733ed210f948ab40
P2860
Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse